Torrent has to its credit, leading brands in various therapeutic segments. It is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Gastro-Intestinal, Diabetology, Anti-infectives and Pain Management.
To sharpen its focus and enhance its customer reach in the domestic market, Torrent operates throughsales and marketing divisions structured on specific Therapeutic areas. Currently, it has 15 sales and marketing divisions- Prima, Vista, Sparsh, Sensa, Mind, Axon, Neuron, Psycan CnD, Psycan, Azuca, Delta, Oncology, B Well, Uno Spirit and Nephro each of which have a clear therapeutic focus.
Recently, Torrent Pharma acquired the branded domestic formulations business of Elder Pharmaceuticals in India and Nepal. The acquisition comprises a portfolio of 30 brands including market-leading brands in the Women's Healthcare, Pain Management, Wound Care and Nutraceuticals therapeutic segments. The transaction will also involve the transfer of employees engaged in sales, marketing and operations of the India Business. Elder Pharma will continue to manufacture & supply the products at its existing manufacturing facilities for Torrent Pharma for a period of three years